Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Discover a solution to control mixed Eosinophilic and Allergic Asthma

Discover a solution to control mixed Eosinophilic and Allergic Asthma

Consider this biologic for Patients with mixed Phenotypes.

Dupixent® (dupilumab) Mechanism of Action

Dupixent® (dupilumab) Mechanism of Action

Consider Dupixent for Asthmatic patients with OCS use

Consider Dupixent for Asthmatic patients with OCS use

Consider Dupixent for Asthmatic patients with high EOS

Consider Dupixent for Asthmatic patients with high EOS

Why is it important to look for Type 2 inflammation in patients with Asthma?

Why is it important to look for Type 2 inflammation in patients with Asthma?

How do you balance the cost of Biologics with the value they can bring to patients?

How do you balance the cost of Biologics with the value they can bring to patients?

How Type 2 inflammation affect patients with Asthma?

How Type 2 inflammation affect patients with Asthma?

What challenges do you face when treating patients with Type 2 inflammation?

What challenges do you face when treating patients with Type 2 inflammation?

When do you discuss Biologic treatment with your Asthma patients?

When do you discuss Biologic treatment with your Asthma patients?

How do you choose the right Biologic for a particular Asthma patients?

How do you choose the right Biologic for a particular Asthma patients?

About Type 2 Inflammation – Asthma

About Type 2 Inflammation – Asthma

aTTP is a Medical Emergency With Long Term Consequences

aTTP is a Medical Emergency With Long Term Consequences